Showing results (1591-1600 of 2,221) with videos related to

Sort By:
Pageof 223
The Journal of Biological Chemistry|October 5, 1993
Metal binding properties of recombinant rat parvalbumin wild-type and F102W mutantT L Pauls, I Durussel, J A Cox, et al.
Human Genetics|March 1, 1996
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitusA I Blakemore, A Cox, A M Gonzalez, et al.
The American Journal of Cardiology|May 29, 1987
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertensionM H Frick, D A Cox, P Himanen, et al.
Diabetes Care|January 5, 2021
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)Juan P Frias, Enzo Bonora, Luis Nevarez Ruiz, et al.
Mutagenesis|January 5, 2021
In vitro mutagenicity of selected environmental carcinogens and their metabolites in MutaMouse FE1 lung epithelial cellsLisa Hölzl-Armstrong, Andrea Nævisdal, Julie A Cox, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Genetic regulatory effects in response to a high cholesterol, high fat diet in baboonsWenhe Lin, Jeffrey D Wall, Ge Li, et al.
Clinical Immunology (Orlando, Fla.)|August 14, 2002
Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosisCarol M Artlett, Lori A Cox, Ronald C Ramos, et al.
Cytokine|September 14, 2001
Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptorC H Jenh, M A Cox, W Hipkin, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metforminJuan P Frias, Alan G Wynne, Beata Matyjaszek-Matuszek, et al.
Bioorganic & Medicinal Chemistry|March 21, 2006
Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analoguesT Mavromoustakos, P Moutevelis-Minakakis, C G Kokotos, et al.
Pageof 223